What is meant by the statement in paragraph 11 of the Attorney Letter Guidelines that counsel has “personally met” with management and a majority of the directors of the Issuer?
This statement describes the process used by competent counsel to perform the work necessary to submit an honest and reliable letter with respect to the issuer’s disclosure (“Information”)posted through the OTC Disclosure and News Service. This process requires counsel to assist the issuer by participating directly in drafting the Information required under Pink OTC Markets’ Guidelines for Providing Adequate Current Information. In drafting this disclosure, the attorney will examine the evidence that supports each material statement made in the Information. Some of this evidence will be physical or documentary, while other evidence will consist of oral statements made to the attorney by executive officers who participated in or directed the events described in the Information. We believe that it is essential for the attorney to interview these officers personally to confirm the material facts described in the Information and clear up discrepancies in the evidence at hand. The attorney
Related Questions
- What is meant by the statement in paragraph 11 of the Attorney Letter Guidelines that counsel has "personally met" with management and a majority of the directors of the Issuer?
- When does the Attorney Letter need to include Exhibit B of OTC Markets Guidelines for Attorney Letters with Respect to Adequate Current Information?
- What is meant by the application of the ‘executive power’ of Ministers in relation to Paragraph 2.4(h) the CPGs?
